I Radevski
Overview
Explore the profile of I Radevski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barlassina C, Norton G, Samani N, Woodwiss A, Candy G, Radevski I, et al.
Am J Hypertens
. 2000 Jul;
13(6 Pt 1):719-23.
PMID: 10912759
The alpha-adducin gene contributes significantly to hypertension in MHS rats (rats of the Milan hypertensive strain) and in some white and Japanese populations, causing a low renin, sodium, and diuretic-sensitive...
2.
Candy G, Samani N, Norton G, Woodiwiss A, Radevski I, Wheatley A, et al.
J Hypertens
. 2000 Feb;
18(2):167-72.
PMID: 10694184
Objective: To determine whether or not beta2 adrenoceptor polymorphism is a risk factor for the development of hypertension in a Black South African population. Background: Attenuated vasodilator responses to endogenous...
3.
Radevski I, Skudicky D, Candy G, Sathekge S, Strugo V, Sareli P
Am J Hypertens
. 1999 Mar;
12(2 Pt 1):194-203.
PMID: 10090348
A single-center, prospective double-blind randomized trial was conducted to compare the efficacy and safety of the calcium channel blocker nisoldipine in a sustained release coat-core formulation (CC), titrated from 10...
4.
Skoularigis J, Strugo V, Radevski I, Hlatswayo Z, Sareli P
Int J Clin Pharmacol Ther
. 1997 Feb;
35(2):51-5.
PMID: 9147707
Using ambulatory blood pressure (BP) monitoring, a potent ACE-inhibitor/calcium channel blocker combination was tested in 21 Black patients (age 52 +/- 10 years; 10 males, 11 females) with mild to...